Basel
Switzerland
2
2022-10-20
Asa Eliasson from Basel, CH has applied for patents for these inventions. The list has both pending applications and granted patents:
USE OF AN MDM2 INHIBITOR FOR THE TREATMENT OF MYELOFIBROSIS
#2 | 2022-09-29USE OF HIGH-AFFINITY, LIGAND-BLOCKING, HUMANIZED ANTI-T-CELL IMMUNOGLOBULIN DOMAIN AND MUCIN DOMAIN-3 (TIM-3) IGG4 ANTIBODY FOR THE TREATMENT OF MYELOFIBROSIS
5530860 ⎘